Search

Joshua Joo

Examiner (ID: 11954, Phone: (571)272-3966 , Office: P/2445 )

Most Active Art Unit
2445
Art Unit(s)
2154, 2454, 2445
Total Applications
1186
Issued Applications
850
Pending Applications
94
Abandoned Applications
264

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6991510 [patent_doc_number] => 20050090547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains' [patent_app_type] => utility [patent_app_number] => 10/727655 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1992 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090547.pdf [firstpage_image] =>[orig_patent_app_number] => 10727655 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/727655
Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains Dec 4, 2003 Issued
Array ( [id] => 7276348 [patent_doc_number] => 20040235799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Use of a compound with a negatively charged domain of radicals for the treatment of restenosis' [patent_app_type] => new [patent_app_number] => 10/478962 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5300 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235799.pdf [firstpage_image] =>[orig_patent_app_number] => 10478962 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/478962
Use of a compound with a negatively charged domain of radicals for the treatment of restenosis Nov 25, 2003 Abandoned
Array ( [id] => 7240009 [patent_doc_number] => 20040157927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{-4-[2-(4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea' [patent_app_type] => new [patent_app_number] => 10/479205 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5977 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157927.pdf [firstpage_image] =>[orig_patent_app_number] => 10479205 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/479205
Pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{-4-[2-(4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea Nov 25, 2003 Abandoned
Array ( [id] => 7226012 [patent_doc_number] => 20040072902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Methods for inducing apoptosis and inhibiting proliferation in cancer cells' [patent_app_type] => new [patent_app_number] => 10/451555 [patent_app_country] => US [patent_app_date] => 2003-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4144 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072902.pdf [firstpage_image] =>[orig_patent_app_number] => 10451555 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/451555
Methods for inducing apoptosis and inhibiting proliferation in cancer cells Nov 23, 2003 Abandoned
Array ( [id] => 7169252 [patent_doc_number] => 20040077609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Oral composition containing NSAIDs and essential oils' [patent_app_type] => new [patent_app_number] => 10/719554 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4664 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077609.pdf [firstpage_image] =>[orig_patent_app_number] => 10719554 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/719554
Oral composition containing NSAIDs and essential oils Nov 20, 2003 Abandoned
Array ( [id] => 5844687 [patent_doc_number] => 20060122261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => '[METHOD OF PREPARING LABDANE DITERPENE COMPOSITION, PREFERABLY ISOFORSKOLIN AND DEACETYLFORSKOLIN FROM FORSKOLIN EXTRACT AND THEIR USE FOR PROMOTING LEAN BODY MASS AND OTHER APPLICATIONS]' [patent_app_type] => utility [patent_app_number] => 10/707087 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3521 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122261.pdf [firstpage_image] =>[orig_patent_app_number] => 10707087 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/707087
[METHOD OF PREPARING LABDANE DITERPENE COMPOSITION, PREFERABLY ISOFORSKOLIN AND DEACETYLFORSKOLIN FROM FORSKOLIN EXTRACT AND THEIR USE FOR PROMOTING LEAN BODY MASS AND OTHER APPLICATIONS] Nov 19, 2003 Abandoned
Array ( [id] => 7475116 [patent_doc_number] => 20040097582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Use of a blood-flow decrease preventing agent in conjunction with insufflating gas' [patent_app_type] => new [patent_app_number] => 10/714980 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3294 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097582.pdf [firstpage_image] =>[orig_patent_app_number] => 10714980 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/714980
Use of a blood-flow decrease preventing agent in conjunction with insufflating gas Nov 17, 2003 Abandoned
Array ( [id] => 7151423 [patent_doc_number] => 20040171697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy' [patent_app_type] => new [patent_app_number] => 10/712546 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6731 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171697.pdf [firstpage_image] =>[orig_patent_app_number] => 10712546 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/712546
Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy Nov 11, 2003 Issued
Array ( [id] => 917335 [patent_doc_number] => 07323479 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => 'Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline' [patent_app_type] => utility [patent_app_number] => 10/704237 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23040 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323479.pdf [firstpage_image] =>[orig_patent_app_number] => 10704237 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/704237
Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline Nov 5, 2003 Issued
Array ( [id] => 7368345 [patent_doc_number] => 20040092571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 10/702930 [patent_app_country] => US [patent_app_date] => 2003-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4626 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092571.pdf [firstpage_image] =>[orig_patent_app_number] => 10702930 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/702930
Pharmaceutical composition Nov 4, 2003 Abandoned
Array ( [id] => 7325612 [patent_doc_number] => 20040138301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Chemical uncouplers for the treatment of obesity' [patent_app_type] => new [patent_app_number] => 10/699338 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 34425 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138301.pdf [firstpage_image] =>[orig_patent_app_number] => 10699338 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/699338
Chemical uncouplers for the treatment of obesity Oct 30, 2003 Abandoned
Array ( [id] => 856830 [patent_doc_number] => 07375089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Rehydration composition' [patent_app_type] => utility [patent_app_number] => 10/697428 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5353 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375089.pdf [firstpage_image] =>[orig_patent_app_number] => 10697428 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/697428
Rehydration composition Oct 29, 2003 Issued
Array ( [id] => 919772 [patent_doc_number] => 07320976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-22 [patent_title] => 'Combination of brimonidine and timolol for topical ophthalmic use' [patent_app_type] => utility [patent_app_number] => 10/685941 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4026 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/320/07320976.pdf [firstpage_image] =>[orig_patent_app_number] => 10685941 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/685941
Combination of brimonidine and timolol for topical ophthalmic use Oct 13, 2003 Issued
Array ( [id] => 7337461 [patent_doc_number] => 20040132798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => '3.7-Diazybicyclo [3.3.1] formulations as antiarrhythmic compounds' [patent_app_type] => new [patent_app_number] => 10/474591 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 24224 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132798.pdf [firstpage_image] =>[orig_patent_app_number] => 10474591 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/474591
3.7-Diazybicyclo [3.3.1] formulations as antiarrhythmic compounds Oct 9, 2003 Abandoned
Array ( [id] => 7199944 [patent_doc_number] => 20040086578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Physiologically acceptable aqueous solutions and methods for their use' [patent_app_type] => new [patent_app_number] => 10/684151 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12032 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20040086578.pdf [firstpage_image] =>[orig_patent_app_number] => 10684151 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/684151
Physiologically acceptable aqueous solutions and methods for their use Oct 9, 2003 Abandoned
Array ( [id] => 7454342 [patent_doc_number] => 20040068006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Method for preventing acute renal failure' [patent_app_type] => new [patent_app_number] => 10/679040 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3481 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20040068006.pdf [firstpage_image] =>[orig_patent_app_number] => 10679040 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/679040
Method for preventing acute renal failure Oct 2, 2003 Abandoned
Array ( [id] => 5801616 [patent_doc_number] => 20060035957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Preventive or remedy for bedsore' [patent_app_type] => utility [patent_app_number] => 10/529721 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7482 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035957.pdf [firstpage_image] =>[orig_patent_app_number] => 10529721 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/529721
Preventive or remedy for bedsore Sep 29, 2003 Abandoned
Array ( [id] => 7674234 [patent_doc_number] => 20040127884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis' [patent_app_type] => new [patent_app_number] => 10/674290 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 27996 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127884.pdf [firstpage_image] =>[orig_patent_app_number] => 10674290 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/674290
Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis Sep 28, 2003 Abandoned
Array ( [id] => 7378854 [patent_doc_number] => 20040220239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions' [patent_app_type] => new [patent_app_number] => 10/669251 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13002 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220239.pdf [firstpage_image] =>[orig_patent_app_number] => 10669251 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/669251
Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions Sep 24, 2003 Abandoned
Array ( [id] => 7281290 [patent_doc_number] => 20040063667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Anti fibrotic agent containing sphingosine 1-phosphate receptor agonist or sphingosine 1-phospate as active ingredient' [patent_app_type] => new [patent_app_number] => 10/661580 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2503 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063667.pdf [firstpage_image] =>[orig_patent_app_number] => 10661580 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/661580
Use of sphingosine 1-phosphate as active ingredient for the treatment of pulmonary fibrosis Sep 14, 2003 Issued
Menu